Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX29 Compared With HLX11

by | Aug 20, 2026 | Clinical Trials | 0 comments

​ Conditions: Health Adult Subjects

Interventions: Drug: HLX29; Drug: HLX11

Sponsors: Shanghai Henlius Biotech

Not yet recruiting Conditions: Health Adult Subjects
Interventions: Drug: HLX29; Drug: HLX11
Sponsors: Shanghai Henlius Biotech
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *